These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18219825)

  • 1. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
    Weinshenker BG; Wingerchuk DM
    Curr Top Microbiol Immunol; 2008; 318():343-56. PubMed ID: 18219825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMO-IgG: a specific biomarker for neuromyelitis optica.
    Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
    Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
    Lennon VA; Wingerchuk DM; Kryzer TJ; Pittock SJ; Lucchinetti CF; Fujihara K; Nakashima I; Weinshenker BG
    Lancet; 2004 Dec 11-17; 364(9451):2106-12. PubMed ID: 15589308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica.
    Wingerchuk DM
    Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO
    Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica pathogenesis and aquaporin 4.
    Graber DJ; Levy M; Kerr D; Wade WF
    J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
    Lana-Peixoto MA; Callegaro D
    Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis Optica-AQP4: an update.
    Benavente E; Paira S
    Curr Rheumatol Rep; 2011 Dec; 13(6):496-505. PubMed ID: 21922173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
    Lennon VA; Kryzer TJ; Pittock SJ; Verkman AS; Hinson SR
    J Exp Med; 2005 Aug; 202(4):473-7. PubMed ID: 16087714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.